Prevalence and Antimicrobial Susceptibility of Bacterial Uropathogens Isolated from Pediatric Patients at Yekatit 12 Hospital Medical College, Addis Ababa, Ethiopia

Table 6

Multidrug resistance pattern of Gram-negative bacteria isolated from pediatric patients at Yekatit 12 Hospital Medical College, Addis Ababa, Ethiopia, 2014.

Combination of antibacterial agent	E. coli no. (%)	Klebsiella spp. no. (%)	Acinetobacter spp. no. (%)	Total no. (%)
AMP, SXT	3 (16.6)	—	—	3 (8.8)
C, SXT	3 (16.6)	—	—	3 (8.8)
CIP, NOR, SXT	1 (5.6)	—	—	1 (2.94)
AMP, SXT, NA, GN	1 (5.6)	—	1 (100)	2 (5.9)
AMP, CIP, SXT, NOR, GN, CAZ, CTX, CXM	4 (22.2)	—	—	4 (11.8)
AMP, SXT, NA, GN, CAZ, CTX, CXM, C	4 (22.2)	4 (26.7)	—	8 (23.5)
CIP, SXT, NA, GN, CAZ, CTX, CXM, NOR, F	1 (5.6)	5 (33.3)	—	6 (17.6)
AMP, SXT, NA, GN, CAZ, CTX, CXM, NOR, F	1 (5.6)	6 (40)	—	7 (20.6)
Total	18 (100)	15 (100)	1 (100)	34 (100)

AMP: augmentin (30 μg); NOR: norfloxacin (30 μg); GN: gentamicin (30 μg); CIP: ciprofloxacin (5 μg); NA: nalidixic acid (30 μg); F: nitrofurantoin (30 μg); CAZ: ceftazidime (30 μg); CTX: cefotaxim (30 μg); C: chloramphenicol (30 μg); SXT: trimethoprim-sulfamethoxazole (1.25/23.75 μg); CXM: cefuroxime (30 μg).